200 related articles for article (PubMed ID: 30123091)
1. Antitumor activity of arsenite in combination with tetrandrine against human breast cancer cell line MDA-MB-231 in vitro and in vivo.
Yuan B; Yao M; Wang X; Sato A; Okazaki A; Komuro H; Hayashi H; Toyoda H; Pei X; Hu X; Hirano T; Takagi N
Cancer Cell Int; 2018; 18():113. PubMed ID: 30123091
[TBL] [Abstract][Full Text] [Related]
2. JNK and Autophagy Independently Contributed to Cytotoxicity of Arsenite combined With Tetrandrine
Yu B; Yuan B; Li J; Kiyomi A; Kikuchi H; Hayashi H; Hu X; Okazaki M; Sugiura M; Hirano T; Fan Y; Pei X; Takagi N
Front Pharmacol; 2020; 11():1087. PubMed ID: 32765280
[TBL] [Abstract][Full Text] [Related]
3. Synergistic cytotoxic effects of arsenite and tetrandrine in human breast cancer cell line MCF-7.
Yao M; Yuan B; Wang X; Sato A; Sakuma K; Kaneko K; Komuro H; Okazaki A; Hayashi H; Toyoda H; Pei X; Hu X; Hirano T; Takagi N
Int J Oncol; 2017 Aug; 51(2):587-598. PubMed ID: 28656245
[TBL] [Abstract][Full Text] [Related]
4. Differentiation induction of human breast cancer cells by arsenite in combination with tetrandrine.
Yu B; Yuan B; Kiyomi A; Kikuchi H; Hayashi H; Hu X; Okazaki M; Sugiura M; Hirano T; Pei X; Takagi N
Am J Transl Res; 2019; 11(12):7310-7323. PubMed ID: 31934280
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxic Effects of Hellebrigenin and Arenobufagin Against Human Breast Cancer Cells.
Zhang Y; Yuan B; Bian B; Zhao H; Kiyomi A; Hayashi H; Iwatani Y; Sugiura M; Takagi N
Front Oncol; 2021; 11():711220. PubMed ID: 34513690
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxic Effects of Arsenite in Combination With Gamabufotalin Against Human Glioblastoma Cell Lines.
Yuan B; Xu K; Shimada R; Li J; Hayashi H; Okazaki M; Takagi N
Front Oncol; 2021; 11():628914. PubMed ID: 33796463
[TBL] [Abstract][Full Text] [Related]
7. Combination of the novel histone deacetylase inhibitor YCW1 and radiation induces autophagic cell death through the downregulation of BNIP3 in triple-negative breast cancer cells in vitro and in an orthotopic mouse model.
Chiu HW; Yeh YL; Wang YC; Huang WJ; Ho SY; Lin P; Wang YJ
Mol Cancer; 2016 Jun; 15(1):46. PubMed ID: 27286975
[TBL] [Abstract][Full Text] [Related]
8. CIP2A is a target of bortezomib in human triple negative breast cancer cells.
Tseng LM; Liu CY; Chang KC; Chu PY; Shiau CW; Chen KF
Breast Cancer Res; 2012 Apr; 14(2):R68. PubMed ID: 22537901
[TBL] [Abstract][Full Text] [Related]
9.
Farghadani R; Seifaddinipour M; Rajarajeswaran J; Abdulla MA; Mohd Hashim NB; Khaing SL; Salehen NB
PeerJ; 2019; 7():e7686. PubMed ID: 31608167
[TBL] [Abstract][Full Text] [Related]
10. Jatamanvaltrate P induces cell cycle arrest, apoptosis and autophagy in human breast cancer cells in vitro and in vivo.
Yang B; Zhu R; Tian S; Wang Y; Lou S; Zhao H
Biomed Pharmacother; 2017 May; 89():1027-1036. PubMed ID: 28292011
[TBL] [Abstract][Full Text] [Related]
11. Cantharidin Inhibits the Growth of Triple-Negative Breast Cancer Cells by Suppressing Autophagy and Inducing Apoptosis in Vitro and in Vivo.
Li HC; Xia ZH; Chen YF; Yang F; Feng W; Cai H; Mei Y; Jiang YM; Xu K; Feng DX
Cell Physiol Biochem; 2017; 43(5):1829-1840. PubMed ID: 29050003
[TBL] [Abstract][Full Text] [Related]
12. The bromodomain inhibitor OTX015 (MK-8628) exerts anti-tumor activity in triple-negative breast cancer models as single agent and in combination with everolimus.
Vázquez R; Riveiro ME; Astorgues-Xerri L; Odore E; Rezai K; Erba E; Panini N; Rinaldi A; Kwee I; Beltrame L; Bekradda M; Cvitkovic E; Bertoni F; Frapolli R; D'Incalci M
Oncotarget; 2017 Jan; 8(5):7598-7613. PubMed ID: 27935867
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effects of mild hyperthermia plus docetaxel therapy on ER(+/-) breast cancer cells and action mechanisms.
Lv F; Yu Y; Zhang B; Liang D; Li ZM; You W
J Huazhong Univ Sci Technolog Med Sci; 2013 Dec; 33(6):870-876. PubMed ID: 24337851
[TBL] [Abstract][Full Text] [Related]
14. Sulforaphane induces autophagy by inhibition of HDAC6-mediated PTEN activation in triple negative breast cancer cells.
Yang F; Wang F; Liu Y; Wang S; Li X; Huang Y; Xia Y; Cao C
Life Sci; 2018 Nov; 213():149-157. PubMed ID: 30352240
[TBL] [Abstract][Full Text] [Related]
15. The role of the polyamine catabolic enzymes SSAT and SMO in the synergistic effects of standard chemotherapeutic agents with a polyamine analogue in human breast cancer cell lines.
Pledgie-Tracy A; Billam M; Hacker A; Sobolewski MD; Woster PM; Zhang Z; Casero RA; Davidson NE
Cancer Chemother Pharmacol; 2010 May; 65(6):1067-81. PubMed ID: 19727732
[TBL] [Abstract][Full Text] [Related]
16. MELK as a potential target to control cell proliferation in triple-negative breast cancer MDA-MB-231 cells.
Li G; Yang M; Zuo L; Wang MX
Oncol Lett; 2018 Jun; 15(6):9934-9940. PubMed ID: 29805690
[TBL] [Abstract][Full Text] [Related]
17. 3-NAntC: A Potent Crotoxin B-Derived Peptide against the Triple-Negative MDA-MB-231 Breast Cancer Cell Line.
Bezerra P; Motti EF
Molecules; 2024 Apr; 29(7):. PubMed ID: 38611925
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of anticancer activities of Poria cocos ethanol extract in breast cancer: In vivo and in vitro, identification and mechanism.
Jiang Y; Fan L
J Ethnopharmacol; 2020 Jul; 257():112851. PubMed ID: 32283190
[TBL] [Abstract][Full Text] [Related]
19. Different mechanisms involved in the berberine-induced antiproliferation effects in triple-negative breast cancer cell lines.
Lin YS; Chiu YC; Tsai YH; Tsai YF; Wang JY; Tseng LM; Chiu JH
J Cell Biochem; 2019 Aug; 120(8):13531-13544. PubMed ID: 30957305
[TBL] [Abstract][Full Text] [Related]
20. Gallic acid induces G1 phase arrest and apoptosis of triple-negative breast cancer cell MDA-MB-231 via p38 mitogen-activated protein kinase/p21/p27 axis.
Lee HL; Lin CS; Kao SH; Chou MC
Anticancer Drugs; 2017 Nov; 28(10):1150-1156. PubMed ID: 28938245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
